Zetia and Respiration abnormal - a phase IV clinical study of FDA data

Summary:

Respiration abnormal is reported as a side effect among people who take Zetia (ezetimibe), especially for people who are female, 60+ old, also take Singulair, and have Gastroesophageal reflux disease.

The phase IV clinical study analyzes which people have Respiration abnormal when taking Zetia. It is created by eHealthMe based on reports of 47,765 people who have side effects when taking Zetia from the FDA, and is updated regularly.

What is Zetia?

Zetia has active ingredients of ezetimibe. It is often used in high blood cholesterol. eHealthMe is studying from 49,113 Zetia users. Check the latest studies of Zetia.

What is Respiration abnormal?

Respiration abnormal (abnormal breathing process) is found to be associated with 667 drugs and 498 conditions by eHealthMe. Check the latest studies of Respiration abnormal.

On Jul, 11, 2026

47,765 people reported to have side effects when taking Zetia.
Among them, 15 people (0.03%) have Respiration abnormal.

Among these 15 people:

What is the gender of people who have Respiration abnormal when taking Zetia? *

female: 53.33 %
male: 46.67 %

What is the age of people who have Respiration abnormal when taking Zetia? *

What are other drugs people take besides Zetia? *

What are other side effects people have besides Respiration abnormal? *

Chest Pain: 6 people, 40.00%
Dyspnea (difficult or laboured breathing): 4 people, 26.67%
Pain: 4 people, 26.67%
Confusional State: 3 people, 20.00%
Fatigue (feeling of tiredness): 3 people, 20.00%
Feeling Abnormal: 3 people, 20.00%
Mental Impairment (a condition affecting the body, perhaps through sight or hearing loss, a mobility difficulty or a health condition): 3 people, 20.00%
Fibromyalgia (a long-term condition which causes pain all over the body): 3 people, 20.00%
Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 3 people, 20.00%
Stress And Anxiety: 3 people, 20.00%

What are the existing conditions these people have? *

Arthritis (form of joint disorder that involves inflammation of one or more joints): 3 people, 20.00%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 20.00%
Asthma: 2 people, 13.33%
Nerve Injury: 2 people, 13.33%
Multiple Myeloma (cancer of the plasma cells): 2 people, 13.33%
Micturition Disorder (disease of passing urine): 2 people, 13.33%
Lung Disorder (lung disease): 2 people, 13.33%
Chest Pain: 2 people, 13.33%
Dyskinesia (abnormality or impairment of voluntary movement): 1 person, 6.67%
Chronic Lymphocytic Leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell)): 1 person, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Zetia and have Respiration abnormal?

- Check whether Respiration abnormal is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Zetia:

Zetia (49,113 reports)

Browse all side effects of Zetia:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Respiration abnormal:

Respiration abnormal (667 drugs)

Browse all the conditions that are associated with Respiration abnormal:

Respiration abnormal (498 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on ezetimibe (the active ingredients of Zetia) and Zetia (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.